Outcomes of specialized residential treatment for adults with obsessive-compulsive disorder

Journal of Psychiatric Practice

Volumn 19, Issue 5, 2013, Pages 429-437

  Björgvinsson, Thröstur ^a,e,h   Hart, Abpp John ^a   Wetterneck, Chad ^b   Barrera, Terri L ^a,f   Chasson, Gregory S ^c   Powell, Dana M ^a,g   Heffelfinger, Susan ^a,h   Stanley, Melinda A ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

^c TOWSON UNIVERSITY   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e MCLEAN HOSPITAL   (United States)

^f UNIVERSITY OF HOUSTON   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h Houston OCD Program   (United States)

Author keywords

Cognitive behavioral therapy; Exposure and response prevention; Obsessive compulsive disorder; Residential; Treatment effectiveness; Treatment resistant

Indexed keywords

ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; CONVERGENT VALIDITY; DEVELOPMENTAL DISORDER; DISSOCIATIVE DISORDER; EATING DISORDER; HEALTH PROGRAM; HUMAN; LIKERT SCALE; OBSESSIONAL BELIEF QUESTIONNAIRE 44; OBSESSIVE COMPULSIVE DISORDER; OUTCOME VARIABLE; PERSONALITY DISORDER; QUALITY OF LIFE; QUESTIONNAIRE; RESIDENTIAL CARE; SOMATOFORM DISORDER; TREATMENT RESPONSE;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; RESIDENTIAL TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885017520     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000435043.21545.60     Document Type: Article

References (47)

1. Karno M, Golding JM, Sorenson SB. The epidemiology of obsessive-compulsive disorder in five U.S. communities. Arch Gen Psychiatry 1988;45:1094-9.
2. Valleni-Basile LA, Garrison CZ, Jackson KL, et al. Fre - quen cy of obsessive compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry 1994;33:782-91.
3. Eisen J, Mancebo M, Pinto A, et al. Impact of obsessivecompulsive disorder on quality of life. Compr Psychiatry 2006;47:270-5.
4. World Health Organization. The world health report 2001-mental health: New understanding, new hope. Geneva, Switzerland: World Health Organization; 2001.
5. Jenike MA. Obsessive-compulsive disorder. N Engl J Med 2004;350:259-65.
6. American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007;164:1-56.
7. Dougherty DD, Rauch SL, Jenike MA. Pharmacotherapy for obsessive compulsive disorder. J Clin Psychol 2004;60: 1195-202.
8. Pato MT, Zohar-Kadouch R, Zohar J, et al. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry 1988;145:1521-5.
9. Ravizza L, Barzega G, Bellino S, et al. Drug treatment of obsessive-compulsive disorder: Long-term trial with clomipramine and selective serotonin reuptake inhibitors. Psychopharmacol Bull 1996;32:167-73.
10. Tolin DF, Hannan S, Maltby N, et al. A randomized controlled trial of self-directed versus therapist-directed cognitive- behavioral therapy for obsessive-compulsive disorder patients with prior medication trials. Behav Ther 2007;38:179-91.
11. Tolin DF, Maltby N, Diefenbach GJ, et al. Cognitive-behavioral therapy for medication nonresponders with obsessive- compulsive disorder: A wait-list-controlled open trial. J Clin Psychiatry2004;65:922-31.
12. Abramowitz J, Franklin M, Foa E. Empirical status of cognitive- behavioral therapy for obsessive-compulsive disorder: A meta-analytic review. Romanian Journal of Cognitive &Behavioral Psychotherapies 2002;2:89-104.
13. Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005;162: 151-61.
14. Eddy KT, Dutra L, Bradley R, et al. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clin Psychol Rev 2004;24: 1011-30.
15. Kobak KA, Greist JH, Jefferson JW, et al. Behavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysis. Psychopharm 1998;136:205-16.
16. Kozak MJ, Liebowitz M, Foa EB. Cognitive behavior therapy and pharmacotherapy for obsessive-compulsive disorder: The NIMH-sponsored collaborative study. In: Goodman WK, Rudorfer MV, Maser JD. Obsessive-compulsive disorder: Contemporary issues in treatment. Hillsdale, NJ: Lawrence Erlbaum; 2000:501-30.
17. Clark DA. Focus on cognition in cognitive behavior therapy for OCD: Is it really necessary? Cogn Behav Ther 2005;34:131-9.
18. Keeley ML, Storch EA, Merlo LJ, et al. Clinical predictors of response to cognitive-behavioral therapy for obsessivecompulsive disorder. Clin Psychol Rev 2008;28:118-30.
19. Steketee G, Lam JN, Chambless DL, et al. Effects of perceived criticism on anxiety and depression during behavioral treatment of anxiety disorders. Behav Res Ther 2007; 45:11-9.
20. Steketee G, Van Noppen B, Lam J, et al. Expressed emotion in families and the treatment of obsessive compulsive disorder. In Session: Psychotherapy in Practice 1998;4: 73-91.
21. Keijsers GP, Schaap CP, Hoogduin CA. The impact of interpersonal patient and therapist behavior on outcome in cognitive-behavior therapy. A review of empirical studies. Behav Modif 2000;24:264-97.
22. Vogel PA, Hansen B, Stiles TC, et al. Treatment motivation, treatment expectancy, and helping alliance as predictors of outcome in cognitive behavioral treatment of OCD. J Behav Ther Exp Psychiatry 2006;37:247-55.
23. Bjrgvinsson T, Hart J, Heffelfinger, S. Obsessive-compulsive disorder: An update on assessment and treatment. J Psychiatr Pract 2007;13:362-72.
24. Pinto A, Mancebo MC, Eisen JL, et al. The Brown Longitudinal Obsessive Compulsive Study: Clinical features and symptoms of the sample at intake. J Clin Psychiatry 2006;67:703-11.
25. Black DW, Gaffney G, Schlosser S, et al. The impact of obsessive-compulsive disorder on the family: Preliminary findings. J Nerv Ment Dis 1998;186:440-2.
26. Magliano L, Tosini P, Guarneri M, et al. Burden on the families of patients with obsessive-compulsive disorder: A pilot study. Eur Psychiatry 1996;11:192-7.
27. Calvocoressi L, Lewis B, Harris M, et al. Family accommodation in obsessive-compulsive disorder. Am J Psychiatry 1995;152:441-3.
28. Chambless DL, Steketee G. Expressed emotion and behavior therapy outcome: A prospective study with obsessivecompulsive and agoraphobic outpatients. J Consult Clin Psychol 1999;67:658-65.
29. Chasson GS, Buhlmann U, Tolin DF. The need for speed: Accelerating OCD recovery using d-cycloserine to enhance exposure and response prevention. Behav Res Ther 2010; 48:675-9.
30. Stewart ES, Stack DE, Farrell C, et al. Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder. J Psychiatr Res 2005;39: 603-9.
31. Bjrgvinsson T, Wetterneck CT, Powell DM, et al. Treat - ment outcome for adolescent OCD in a specialized hospital setting. J Psychiatr Pract 2008;14:137-45.
32. Boschen MJ, Drummond LM, Pillay A. Treatment of severe, treatment-refractory obsessive-compulsive disorder: A study of inpatient and community treatment. CNS Spectrum 2008;13:1056-65.
33. Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-9.
34. Steketee G, Frost R, Bogart K. The Yale-Brown Obsessive Compulsive Scale: Interview versus self-report. Behav Res Ther 1996;34:675-84.
35. Blais MA, Lenderking WR, Baer L, et al. Development and initial validation of a brief mental health outcome measure. J Pers Assess 1999;73:359-73.
36. Obsessive Compulsive Cognitions Working Group. Psycho - metric validation of the Obsessive Beliefs Questionnaire and the Interpretation of Intrusions Inventory-Part 2: Factor analyses and testing of a brief version. Behav Res Ther 2005;43:1527-42.
37. Spielberger CD. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto, CA: Consulting Psychologists Press; 1983.
38. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4: 561-71.
39. Beck, AT. Depression: Causes and treatment. Phila - delphia: University of Pennsylvania Press; 1967.
40. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
41. Young JL, Waehler CA, Laux JM, et al. Four studies extending the utility of the Schwartz Outcome Scale (SOS- 10). J Pers Assess 2003;80:130-8.
42. Cohen J. A power primer. Psychol Bull 1992;112:155-9.
43. Abramowitz JS. Treatment of obsessive-compulsive disorder in patients who have comorbid major depression. J Clin Psychol 2004;60:1133-41.
44. Abramowitz JS, Franklin ME, Street GP, et al. Effects of comorbid depression on response to treatment for obsessive- compulsive disorder. Behav Ther 2000;31:517-28.
45. Overbeek T, Schruers K, Vermetten E, et al. Comorbidity of obsessive-compulsive disorder and depression: Preva - lence, symptom severity, and treatment effect. J Clin Psychiatry 2002;63:1106-12.
46. Solem S, Haland AT, Vogel PA. Change in metacognitions predicts outcome in obsessive-compulsive disorder patients undergoing treatment with exposure and response prevention. Behav Res Ther 2009;47:301-7.
47. Barrett MS, Chua W, Crits-Christoph P, et al. Early withdrawal from mental health treatment: Implications for psychotherapy practice. Psychotherapy (Chic) 2008;45: 247-67.